↓ Skip to main content

Beta-blocker use and COPD mortality: a systematic review and meta-analysis

Overview of attention for article published in BMC Pulmonary Medicine, September 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
99 Dimensions

Readers on

mendeley
94 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Beta-blocker use and COPD mortality: a systematic review and meta-analysis
Published in
BMC Pulmonary Medicine, September 2012
DOI 10.1186/1471-2466-12-48
Pubmed ID
Authors

Mahyar Etminan, Siavash Jafari, Bruce Carleton, John Mark FitzGerald

Abstract

Despite the benefits of beta-blockers in patients with established or sub-clinical coronary artery disease, their use in patients with chronic obstructive pulmonary disease (COPD) has been controversial. Currently, no systematic review has examined the impact of beta-blockers on mortality in COPD.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 94 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 1%
United Kingdom 1 1%
United States 1 1%
Kenya 1 1%
Unknown 90 96%

Demographic breakdown

Readers by professional status Count As %
Other 13 14%
Researcher 12 13%
Student > Bachelor 11 12%
Student > Master 10 11%
Student > Ph. D. Student 7 7%
Other 19 20%
Unknown 22 23%
Readers by discipline Count As %
Medicine and Dentistry 45 48%
Pharmacology, Toxicology and Pharmaceutical Science 7 7%
Nursing and Health Professions 5 5%
Agricultural and Biological Sciences 4 4%
Economics, Econometrics and Finance 2 2%
Other 5 5%
Unknown 26 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 September 2012.
All research outputs
#13,366,719
of 22,675,759 outputs
Outputs from BMC Pulmonary Medicine
#738
of 1,893 outputs
Outputs of similar age
#92,517
of 169,085 outputs
Outputs of similar age from BMC Pulmonary Medicine
#9
of 25 outputs
Altmetric has tracked 22,675,759 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,893 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 169,085 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.